COCP - Cocrystal Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--789
Cost of Revenue5,822101,67947,2614,071
Gross Profit-5,822-101,679-47,183-4,062
Operating Expenses
Research Development----
Selling General and Administrative2,4404,1406,7651,737
Non Recurring----
Total Operating Expenses8,262105,81954,0265,808
Operating Income or Loss-8,262-105,819-53,948-5,799
Income from Continuing Operations
Total Other Income/Expenses Net7691,551-11,4225,648
Earnings Before Interest and Taxes-8,262-105,819-53,948-5,799
Interest Expense-7-7-7-7
Income Before Tax-7,493-104,268-65,370-151
Income Tax Expense-6,880-29,394-15,248-52
Minority Interest----
Net Income From Continuing Ops-613-74,874-50,122-99
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-613-74,874-50,122-99
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-613-74,874-50,122-99